Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -297.40K | -809.40K | -646.40K | -851.90K | -575.70K |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -347.70K | 464.90K | 14.90K | 472.40K | 174.10K |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | -645.10K | -344.50K | -631.50K | -379.40K | -401.60K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 508.00K | 36.00K | 314.00K | 50.00K | 46.20K |
| Total Debt Repaid | -- | -209.60K | -- | -7.00K | -28.50K |
| Issuance of Common Stock | 446.90K | 427.50K | 762.50K | 172.50K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 175.00K | -175.00K | -- | -- |
| Cash from Financing | 682.20K | 314.40K | 658.80K | 159.80K | 13.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 37.10K | -30.00K | 27.30K | -219.60K | -388.60K |
